Norbert Žilka
Norbert Žilka publishes mostly in Physiology, Molecular Biology and Neurology, on topics such as Alzheimer's disease research and treatments, Neuroinflammation and Neurodegeneration Mechanisms and Neuroscience and Neuropharmacology Research.
- World rank
- #647,684 of 7,710,434 ranked researchers
- Rank in Slovakia
- #197 of 12,450
- Works
- 140
- Citations
- 5k
- Citations per work
- 36.0
What does Norbert Žilka research?
Norbert Žilka's work is mostly in Medicine (28%), Neuroscience (23%), Biochemistry, Genetics and Molecular Biology (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences5740.4%
- Neuroscience3223.0%
- Biochemistry, Genetics and Molecular Biology2417.4%
- Everything else4531.9%
- Health Sciences3927.7%
- Medicine3927.7%
- 1Physiology24% of their works
- 2Molecular Biology14% of their works
- 3Neurology13% of their works
- 4Cellular and Molecular Neuroscience10% of their works
- 5Psychiatry and Mental health4% of their works
- 6Genetics3% of their works
Research topics
- Alzheimer's disease research and treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Neuroscience and Neuropharmacology Research
- Dementia and Cognitive Impairment Research
- Cholinesterase and Neurodegenerative Diseases
- Mitochondrial Function and Pathology
- Tryptophan and brain disorders
- Human-Animal Interaction Studies
Which keywords describe Norbert Žilka's research?
The keywords of their largest research topics: Neuroinflammation, Neurodegeneration, Oxidative Stress, Amyloid Hypothesis, Tau Pathology, Cytokines, Microglia and Astrocytes.
- Genomic Analysis
- Tryptophan Metabolism
- Reactive Oxygen Species
- Cholinesterase Inhibitors
- Mild Cognitive Impairment
- Neurodegenerative Diseases
- Synaptic Plasticity
- Alzheimer's Disease
- Astrocytes
- Cytokines
- Amyloid Hypothesis
- Neurodegeneration
- Neuroinflammation
- Oxidative Stress
- Tau Pathology
- Microglia
- Synaptic Pruning
- Neurotransmission
- Aging
- Dementia
- Acetylcholinesterase
- Mitochondria
- Depression
- Dog Domestication
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Neuroinflammation1213 topics
- Neurodegeneration1142 topics
- Oxidative Stress963 topics
- Amyloid Hypothesis811 topic
- Tau Pathology811 topic
- Cytokines402 topics
- Microglia402 topics
- Astrocytes331 topic
- Synaptic Pruning331 topic
- Alzheimer's Disease252 topics
- Neurotransmission241 topic
- Synaptic Plasticity241 topic
- Aging222 topics
- Neurodegenerative Diseases192 topics
- Dementia141 topic
- Mild Cognitive Impairment141 topic
- Acetylcholinesterase111 topic
- Cholinesterase Inhibitors111 topic
- Mitochondria81 topic
- Reactive Oxygen Species81 topic
- Depression71 topic
- Tryptophan Metabolism71 topic
- Dog Domestication61 topic
- Genomic Analysis61 topic
Where does Norbert Žilka work?
Norbert Žilka's main affiliation in the publication record is Institute of Neuroimmunology of the Slovak Academy of Sciences, Slovakia.
How many publications and citations does Norbert Žilka have?
OpenAlex counts 140 works and 5,034 citations for Norbert Žilka, an h-index of 39, ranking #647,684 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Norbert Žilka. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.